scispace - formally typeset
J

Jeroen Kortekaas

Researcher at Wageningen University and Research Centre

Publications -  83
Citations -  2034

Jeroen Kortekaas is an academic researcher from Wageningen University and Research Centre. The author has contributed to research in topics: Virus & Rift Valley fever. The author has an hindex of 24, co-authored 75 publications receiving 1569 citations. Previous affiliations of Jeroen Kortekaas include Utrecht University.

Papers
More filters
Journal ArticleDOI

Creation of a Nonspreading Rift Valley Fever Virus

TL;DR: It is demonstrated that a single intramuscular vaccination with RRPs protects mice from a lethal dose of RVFV and show that RRPs can be used for rapid virus neutralization tests that do not require biocontainment facilities.
Journal ArticleDOI

Heparan sulfate facilitates Rift Valley fever virus entry into the cell

TL;DR: It is reported that the glycosaminoglycan heparan sulfate, abundantly present on the surface of most animal cells, is required for efficient entry of Rift Valley fever virus.
Journal ArticleDOI

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge

TL;DR: Evaluation of two vaccine candidates based on the viral Gn and Gc envelope glycoproteins produced in a Drosophila insect cell expression system shows absence of the nucleocapsid protein in either vaccine candidate facilitates the differentiation between infected and vaccinated animals using a commercial recombinant nucleocAPSid protein-based indirect ELISA.
Journal ArticleDOI

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector

TL;DR: The production of Gn and Gc is reported by a recombinant vaccine strain of the avian paramyxovirus Newcastle disease virus (NDV) and it is demonstrated that intramuscular vaccination with this experimental NDV-based vector vaccine provides complete protection in mice.